# Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood

> **NCT04699903** · — · COMPLETED · sponsor: **Lumos Diagnostics** · enrollment: 201 (actual)

## Conditions studied

- SARS-Cov-2, Covid19

## Interventions

- **DIAGNOSTIC_TEST:** POC SARS-Cov-2 IgG Antibody test

## Key facts

- **NCT ID:** NCT04699903
- **Lead sponsor:** Lumos Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-05
- **Primary completion:** 2021-01-29
- **Final completion:** 2021-04-09
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2021-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04699903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04699903, "Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT04699903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*